345 related articles for article (PubMed ID: 10791099)
1. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
2. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.
Lippa CF; Fujiwara H; Mann DM; Giasson B; Baba M; Schmidt ML; Nee LE; O'Connell B; Pollen DA; St George-Hyslop P; Ghetti B; Nochlin D; Bird TD; Cairns NJ; Lee VM; Iwatsubo T; Trojanowski JQ
Am J Pathol; 1998 Nov; 153(5):1365-70. PubMed ID: 9811326
[TBL] [Abstract][Full Text] [Related]
3. Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.
Frigerio I; Bouwman MMA; Noordermeer RTGMM; Podobnik E; Popovic M; Timmermans E; Rozemuller AJM; van de Berg WDJ; Jonkman LE
Acta Neuropathol Commun; 2024 Jan; 12(1):4. PubMed ID: 38173031
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
6. LRP10 and α-synuclein transmission in Lewy body diseases.
Carreras Mascaro A; Grochowska MM; Boumeester V; Dits NFJ; Bilgiҫ EN; Breedveld GJ; Vergouw L; de Jong FJ; van Royen ME; Bonifati V; Mandemakers W
Cell Mol Life Sci; 2024 Feb; 81(1):75. PubMed ID: 38315424
[TBL] [Abstract][Full Text] [Related]
7. Structures of α-synuclein filaments from human brains with Lewy pathology.
Yang Y; Shi Y; Schweighauser M; Zhang X; Kotecha A; Murzin AG; Garringer HJ; Cullinane PW; Saito Y; Foroud T; Warner TT; Hasegawa K; Vidal R; Murayama S; Revesz T; Ghetti B; Hasegawa M; Lashley T; Scheres SHW; Goedert M
Nature; 2022 Oct; 610(7933):791-795. PubMed ID: 36108674
[TBL] [Abstract][Full Text] [Related]
8. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Grochowska MM; Carreras Mascaro A; Boumeester V; Natale D; Breedveld GJ; Geut H; van Cappellen WA; Boon AJW; Kievit AJA; Sammler E; ; Parchi P; Cortelli P; Alessi DR; van de Berg WDJ; Bonifati V; Mandemakers W
Acta Neuropathol; 2021 Jul; 142(1):117-137. PubMed ID: 33913039
[TBL] [Abstract][Full Text] [Related]
9. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.
Schulz-Schaeffer WJ
Acta Neuropathol; 2010 Aug; 120(2):131-43. PubMed ID: 20563819
[TBL] [Abstract][Full Text] [Related]
10. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Hasegawa M; Goedert M
Proc Natl Acad Sci U S A; 1998 May; 95(11):6469-73. PubMed ID: 9600990
[TBL] [Abstract][Full Text] [Related]
11. The heart of PD: Lewy body diseases as neurocardiologic disorders.
Goldstein DS; Sharabi Y
Brain Res; 2019 Jan; 1702():74-84. PubMed ID: 29030055
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of novel proteins in cortical lewy bodies.
Leverenz JB; Umar I; Wang Q; Montine TJ; McMillan PJ; Tsuang DW; Jin J; Pan C; Shin J; Zhu D; Zhang J
Brain Pathol; 2007 Apr; 17(2):139-45. PubMed ID: 17388944
[TBL] [Abstract][Full Text] [Related]
13. LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.
Alegre-Abarrategui J; Ansorge O; Esiri M; Wade-Martins R
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):272-83. PubMed ID: 17971075
[TBL] [Abstract][Full Text] [Related]
14. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
[TBL] [Abstract][Full Text] [Related]
15. Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.
Tong M; Dong M; de la Monte SM
J Alzheimers Dis; 2009; 16(3):585-99. PubMed ID: 19276553
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles.
Meade RM; Fairlie DP; Mason JM
Mol Neurodegener; 2019 Jul; 14(1):29. PubMed ID: 31331359
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein: Experimental Pathology.
Hasegawa M; Nonaka T; Masuda-Suzukake M
Cold Spring Harb Perspect Med; 2016 Sep; 6(9):. PubMed ID: 27481772
[TBL] [Abstract][Full Text] [Related]
18. Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases.
Moors TE; Morella ML; Bertran-Cobo C; Geut H; Udayar V; Timmermans-Huisman E; Ingrassia AMT; Brevé JJP; Bol JGJM; Bonifati V; Jagasia R; van de Berg WDJ
Acta Neuropathol; 2024 Apr; 147(1):67. PubMed ID: 38581586
[TBL] [Abstract][Full Text] [Related]
19. Neuronal SNCA transcription during Lewy body formation.
Kon T; Forrest SL; Lee S; Martinez-Valbuena I; Li J; Nassir N; Uddin MJ; Lang AE; Kovacs GG
Acta Neuropathol Commun; 2023 Nov; 11(1):185. PubMed ID: 37996943
[TBL] [Abstract][Full Text] [Related]
20. In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons.
Fouka M; Mavroeidi P; Tsaka G; Xilouri M
Front Cell Dev Biol; 2020; 8():559791. PubMed ID: 33015057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
